Hong Kong listed biotechnology company Insilico Medicine has expanded its global footprint through a new partnership in the United Arab Emirates aimed at accelerating artificial intelligence driven drug discovery. The agreement was signed with the UAE’s national drug regulator during a major healthcare
China and Hong Kong are being encouraged to relax listing requirements for biotechnology companies as investors seek to accelerate growth in the healthcare sector. Venture capital leaders and industry participants argue that regulatory adjustments could help innovative biotech firms gain faster access to
China’s biotechnology sector has recorded a sharp rise in international licensing deals during the opening months of 2026, highlighting the country’s growing influence in global pharmaceutical research and drug development. The total value of outlicensing agreements signed by Chinese biotech companies in the
Diagnostics startup Droplet Biosciences has announced a collaboration with Nvidia to accelerate the processing of genomic data used in post surgery cancer testing, aiming to significantly shorten the time patients wait for critical results. The company is integrating Nvidia’s GPU accelerated computing infrastructure,
Chinese artificial intelligence driven drug discovery firm XtalPi Holdings has projected its first full year profit following a sharp rise in revenue, signaling growing commercial traction for AI powered pharmaceutical research in China. The Shenzhen based company said it expects to report a
Chinese smartphone brand Honor has introduced a robot phone and its first humanoid companion as part of an aggressive expansion into artificial intelligence powered hardware, signaling a new phase of competition in the global Android ecosystem. The announcement came ahead of MWC Barcelona,
China’s biotechnology sector is entering a new phase of financial maturity as companies move beyond heavy reliance on licensing agreements and tap deeper pools of domestic and international capital. Strong equity market performance, regulatory reforms and expanding innovation pipelines are reshaping the funding
Google has disrupted a Chinese linked cyber espionage operation that compromised at least 53 organizations across 42 countries, according to findings released by the company’s Threat Intelligence Group. The campaign, attributed to a group tracked as UNC2814 and also known as Gallium, is
Chinese smartphone maker Honor is set to enter the humanoid robotics arena with the launch of its first household focused robot, marking a significant expansion beyond its traditional mobile device business. The Shenzhen based company confirmed that the unveiling will take place on
Chinese biotechnology companies are accelerating their push into global markets, with Shanghai based Harbour BioMed announcing a partnership valued at more than US$1.2 billion to advance one of its clinical stage antibody therapies outside mainland China. The agreement underscores a broader shift in
